The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.

Thank you for being a part of the Cancer Survivor Network community. Survivors and caregivers like you have played a unique role in fostering an online environment that encourages connection among those needing support, community, and education. On May 28, the Network will be discontinued. More details are available here . If you have any questions, contact CSNSupportTeam@cancer.org. Thanks again for the support you’ve provided each other over the years. We remain committed to supporting you in other ways throughout your cancer journey.

Lenvima/Lenvatinib

Williamryan
Williamryan CSN Member Posts: 37
in Thyroid Cancer #1

Lenvima/lenvatinib has just been approved for papillary thyroid cancer treatment that is resistant to RI-131.   It just came off of clinical trials and the FDA had put it on the fast track for approval.  Has anyone tried this new chemo pill?  My oncologist is recommending this for me since Nexavar and Zelboraf had no effect on me.

Thanks,

Bill

Like Care

Discussion Boards